Morocco,South Africa,Australia,China,Hong Kong SAR China,Japan,Korea,New Zealand,Singapore,Thailand,Austria,Belgium,Czech Republic,Denmark,Finland,France,Germany,Hungary,Ireland,Italy,Luxembourg,Netherlands,Norway,Poland,Portugal,Romania,Slovak Republic,Spain,Sweden,United Kingdom,Argentina,Chile,Mexico,Peru,Bahrain,Oman,Qatar,UAE,Canada,Puerto Rico,United States
Every day, life sciences companies are improving outcomes and changing lives. Litigation can disrupt this progress and cut to the core of your business. We’re here to help. With bold solutions to every challenge, we partner with clients across the life sciences industry to quickly mitigate, limit, and resolve claims and disputes.
Our global team of lawyers in 40+ countries guide clients through some of the most complex and challenging disputes and litigation in the Life Sciences industry. These include government investigations and contractual disputes, product liability claims, antitrust, class actions, mass tort claims, and multidistrict litigation.
Our litigators are well versed in science – we craft legal strategies informed by both legal knowledge and scientific nuance. Many of our team members are scientists by training, with PhDs or other advanced scientific degrees, and can translate technical facts to judges, juries, and expert witnesses – an advantage in trials.
“Their strength is that they work as a team. They know their strengths and bring people in for all areas of mass torts, from science experts to coordinators.”
Client, Chambers USA 2021
At every step of the product and regulatory lifecycle, we can advise on protecting your reputation, products, and revenue streams, particularly products under patent protection.
From enhanced AI capabilities to decentralized clinical trials, new technologies and processes are changing the nature of liability and risk. Combined with pricing and distribution issues, and increased enforcement activity, today’s challenges require modern solutions. We provide a coordinated approach across practice areas and jurisdictions and innovative legal advice. We’ll work closely with you to solve issues in emerging areas of law and develop flexible solutions that protect your business and maintain your competitive edge. This includes using our best-in-class AI tool, Aiscension, to help you identify the risks of prohibited, anti-competitive cartel activity.
With a focus on achieving success through early actions and disposition of claims, we navigate the complexities and subtleties of life sciences litigation to protect our clients and strengthen the law. From advising the world’s leading medical device company to achieving groundbreaking legal victories for pharmaceutical clients, our teams consistently resolve claims and bring mass torts to an early end.
Novo Nordisk, a global pharmaceutical company, in nationwide litigation involving Victoza® and other incretin-based diabetes therapies. After nearly eight years of litigation and more than 300 filed cases, obtained exclusion of plaintiffs' general causation experts and summary judgment on federal preemption grounds, effectively ending the litigation and securing important causation and preemption precedent for pharmaceutical manufacturers.
Sanofi as co-national counsel in litigation and regulatory proceedings arising from allegations that Zantac® (ranitidine) contained NDMA. The firm played a leading role in scientific and expert strategy and helped secure exclusion of plaintiffs' general causation experts, effectively ending the federal MDL, one of the most significant pharmaceutical mass tort victories in US history.
Bayer, a global life sciences company, in litigation involving Essure®, an implantable contraceptive device. As lead strategic and global coordinating counsel, helped resolve approximately 90% of claims and coordinated litigation strategy across 12 countries, achieving more than 80 favorable trial and appellate outcomes in jurisdictions including France, Brazil, Spain, and Canada.
Pfizer, a global biopharmaceutical company, in multidistrict litigation involving Chantix®. As national counsel, obtained summary judgment and dismissal of all claims, resulting in a complete defense victory.
Bristol Myers Squibb and Pfizer, global biopharmaceutical companies, in litigation involving Eliquis®. As national counsel, obtained dismissal of all claims on federal preemption grounds before discovery, with the dismissal subsequently affirmed by the Second Circuit.
Pfizer and Eli Lilly, global biopharmaceutical companies, in litigation involving Viagra® and Cialis®. As co-national counsel, secured exclusion of plaintiffs' general causation experts, effectively ending the litigation.
Pfizer, a global biopharmaceutical company, in multidistrict litigation involving Depo-Provera®, a contraceptive injectable product. As national counsel, represent the company in litigation involving approximately 13,000 plaintiffs and complex scientific, regulatory, and causation issues.
Merck, a global pharmaceutical company, in landmark EU and UK competition proceedings involving alleged "pay-for-delay" pharmaceutical patent settlement agreements. The matter addresses novel issues at the intersection of patent law, regulatory approval, and antitrust enforcement.
Sanofi, a global biopharmaceutical company, in a high-stakes R&D licensing dispute concerning NK-92 cell technology and its Sarclisa® (isatuximab) product. The matter involves claims for royalties tied to worldwide commercial sales.
Caelum, Inc., a biotechnology company acquired by Alexion Pharmaceuticals, in a commercial dispute involving antibody technology for AL amyloidosis. The matter includes claims for trade secret misappropriation, breach of contract, and tortious interference.
